Abstract
While conventional mapping techniques, guided by fluoroscopy, have been very successful in guiding mapping and ablation of stable arrhythmias with predictable anatomical locations or characteristics identifying endocardial electrograms, those techniques often are inadequate for more complex atrial and ventricular arrhythmias. This stems in part from the limitations of fluoroscopy and conventional catheter-based mapping techniques to localize arrhythmogenic substrates that are removed from fluoroscopic landmarks and the lack of characteristic electrographic patterns for ablation targets.
Several advanced mapping systems have been developed to overcome some of the limitations of conventional mapping and have offered new insights into arrhythmia mechanisms. These systems are aimed at improving mapping resolution, three-dimensional (3-D) spatial localization, and rapid acquisition of cardiac activation maps. Additionally, technological advances have allowed remote catheter navigation as well as nonfluoroscopic electromagnetic catheter tracking.
Electroanatomical mapping systems use novel approaches to determine the 3-D location of the mapping catheter accurately, while local electrograms are acquired using conventional methods. Recorded data of the catheter location and associated intracardiac electrogram at that location are used to reconstruct in real time a representation of the 3-D geometry of the cardiac chamber, color-coded with relevant electrophysiological information (local activation time and electrogram amplitude), as well as purely anatomical chamber mapping.
Importantly, these systems must be used as an adjunctive tool to facilitate mapping and ablation, and the integration of anatomical, electrophysiological, and software information by an experienced physician remains an indispensable prerequisite to accomplish a safe and successful procedure.
Keywords
electroanatomical mapping, noncontract mapping, robotic navigation, magnetic navigation, intracardiac echocardiography, computed tomography
Outline
Electroanatomic Mapping, 156
Fundamental Concepts, 156
Electroanatomic Activation Mapping, 161
Electroanatomic Voltage Mapping, 169
High-Resolution Electroanatomic Mapping, 171
Ripple Mapping, 172
Anatomical Mapping, 172
Clinical Implications, 174
Choice of Electroanatomic Mapping System, 175
EnSite Noncontact Mapping System, 176
Basket Catheter Mapping, 180
Focal Impulse and Rotor Mapping, 182
Stereotaxis Magnetic Navigation System, 183
Sensei Robotic Navigation System, 186
Mediguide Navigation System, 187
Body Surface Potential Mapping, 188
Electrocardiographic Mapping, 190
Intracardiac Echocardiography, 193
Computed Tomography and Magnetic Resonance Imaging, 197
Fundamental Concepts, 197
Image Integration Technique, 198
Clinical Implications, 199
Limitations, 201
Three-Dimensional Rotational Angiography, 202
Conventional radiofrequency (RF) ablation has revolutionized the treatment of many supraventricular as well as ventricular arrhythmias. Success in stable arrhythmias with predictable anatomical locations or characteristics identifying endocardial electrograms, such as idiopathic ventricular tachycardia (VT), atrioventricular nodal reentrant tachycardia (AVNRT), atrioventricular reentrant tachycardia (AVRT), or typical atrial flutter (AFL), has approached 90% to 99%. However, as interest has turned to a broad array of more complex arrhythmias, including some atrial tachycardias (ATs), many forms of intraatrial reentry, most VTs, and atrial fibrillation (AF), ablation of such arrhythmias continues to pose a major challenge. This stems in part from the limitations of fluoroscopy and conventional catheter-based mapping techniques to localize arrhythmogenic substrates that are removed from fluoroscopic landmarks and the lack of characteristic electrographic patterns for ablation targets.
The use of fluoroscopy for these purposes can be problematic for several reasons: (1) intracardiac electrograms cannot be associated accurately with their precise location within the heart; (2) the endocardial surface is invisible using fluoroscopy, and target sites may be approximated only by their relationship with nearby structures, such as ribs, blood vessels, and the position of other catheters; (3) fluoroscopy-guided catheter navigation is not exact, is time-consuming, and requires multiple views to estimate the three-dimensional (3-D) location of the catheter; (4) the catheter cannot accurately and precisely be returned to a previously mapped site; and (5) the patient and medical team are exposed to radiation.
Newer mapping systems have transformed the clinical electrophysiology (EP) laboratory, have enabled physicians to overcome some of the limitations of conventional mapping, and have offered new insights into arrhythmia mechanisms. These systems are aimed at improving mapping resolution, 3-D spatial localization, and rapidity of acquisition of cardiac activation maps. The application of these various techniques for mapping specific arrhythmias is described elsewhere in this text, as are the details of the diagnosis, mapping, and treatment of specific arrhythmias.
However, to date, the integration of anatomical, EP, and software information by an experienced physician is an indispensable prerequisite to accomplish a safe and successful procedure. At most, such systems must be used as an adjunctive tool to facilitate mapping and ablation. The operator should understand the advantages and shortcomings of each system, and should recognize that these systems can be misleading and confusing, providing inaccurate information as a result of either incorrect data acquisition or inherent limitations of the technology.
Electroanatomic Mapping
Electroanatomic mapping systems use novel approaches to determine the 3-D location of the mapping catheter accurately, while local electrograms are acquired using conventional methods. Recorded data of the catheter location and associated intracardiac electrogram at that location are used to reconstruct in real time a representation of the 3-D geometry of the cardiac chamber, color-coded with relevant EP information (local activation time and electrogram amplitude), as well as purely anatomical chamber mapping.
At the present time, three electroanatomic mapping systems are in clinical use: (1) CARTO (Biosense Webster, Diamond Bar, CA, United States); (2) EnSite NavX (St. Jude Medical, St. Paul, MN, United States); and (3) Rhythmia (Boston Scientific, Cambridge, MA, United States). These systems use electromagnetic or impedance-based catheter location methods, or a hybrid of both.
Fundamental Concepts
CARTO Electroanatomic Mapping System
The CARTO mapping system consists of an ultralow magnetic field emitter, a magnetic field generator locator pad (placed beneath the operating table), an external reference patch (fixed on the patient’s back), a deflectable 7 Fr quadripolar mapping-ablation catheter with a 4- or 8-mm tip and proximal 2-mm ring electrodes, location sensors inside the mapping-ablation catheter tip (the three location sensors are located orthogonally to each other and lie just proximal to the tip electrode, totally embedded within the catheter), a reference catheter, a data processing unit, and a graphic display unit to generate the electroanatomic model of the chamber being mapped.
The CARTO electroanatomic mapping is based on the premise that a metal coil generates an electrical current when it is placed in a magnetic field. The magnitude of the current depends on the strength of the magnetic field and the orientation of the coil in it. The CARTO mapping system uses a triangulation algorithm similar to that used by a global positioning system (GPS). The magnetic field emitter, mounted under the operating table, consists of three coils that generate a low-intensity magnetic field (5 × 10 −6 to 5 × 10 −5 T) that is a very small fraction of the magnetic field intensity inside a magnetic resonance imaging (MRI) machine ( Fig. 6.1 ).
The sensor embedded proximal to the tip of a specialized mapping catheter detects the intensity of the magnetic field generated by each coil and allows for the determination of its distance from each coil. These distances determine the area of theoretical spheres around each coil, and the intersection of these three spheres determines the exact position and orientation of the tip of the catheter, in relation to a reference sensor on the skin. The accuracy of the determination of the location is highest in the center of the magnetic field; therefore it is important to position the location pad under the patient’s chest. In addition to the x , y , and z coordinates of the catheter tip, the CARTO system can determine three orientation determinants—roll, yaw, and pitch—for the electrode at the catheter tip. The position and orientation of the catheter tip can be seen on the screen and monitored in real time as the catheter moves within the electroanatomic model of the chamber mapped. The catheter icon has four color bars (green, red, yellow, and blue), enabling the operator to view the catheter as it turns clockwise or counterclockwise. In addition, because the catheter always deflects in the same direction, each catheter will always deflect toward a single color. Hence, to deflect the catheter to a specific wall, the operator should first turn the catheter so that this color faces the desired wall.
The unipolar and bipolar electrograms recorded by the mapping catheter at each endocardial site are archived within that positional context. Using this approach, local tissue activation at each successive recording site produces activation maps within the framework of the acquired surrogate geometry.
When mapping the heart, the system can deal with four types of motion artifacts: cardiac motion (the heart is in constant motion; thus the location of the mapping catheter changes throughout the cardiac cycle), respiratory motion (intrathoracic change in the position of the heart during the respiratory cycle), patient motion, and system motion. Several steps are taken by the CARTO mapping system to compensate for these possible motion artifacts, and to ensure that the initial map coordinates are appropriate, including using a reference electrogram and an anatomical reference.
CARTO-3.
The CARTO-3 system is the third-generation platform from Biosense Webster that offers two additional features: Advanced Catheter Location Technology and Fast Anatomical Mapping (FAM). Advanced Catheter Location technology is a hybrid technology that combines magnetic location technology and current-based visualization data to provide accurate visualization of multiple catheter tips and curves on the electroanatomic map. It allows the visualization of up to five EP catheters (with and without the magnetic sensors) simultaneously with clear distinction of all electrodes. In addition to the previously noted magnetic field, CARTO-3 uses an electrical field created by two sets of patches (three on the patient’s back, three on the chest). The system sends a low-intensity current at a unique frequency that is emitted by various catheter electrodes, and the strength of the current emitted by each electrode is measured at each patch; this creates a current ratio unique to each electrode’s location. The magnetic technology calibrates the current-based technology and thereby minimizes distortions at the periphery of the electrical field. Visualization of catheters is confined into a 3-D virtual area called the “matrix,” which can be built only by using a magnetic sensor-equipped manufacturer-specific catheter ( Figs. 6.1 and 6.2 ).
Mapping is performed in two steps. Initially the magnetic mapping permits precise localization of the catheter with the sensor. This is associated with the current ratio of the electrode closest to the sensor. As the catheter with the sensor moves around a chamber, multiple locations are acquired and stored by the system. The system integrates the current-based points with their respective magnetic locations, resulting in a calibrated current-based field that permits accurate visualization of other catheters and their locations. Since each electrode emits a unique frequency, individual electrode locations are distinct, even when they are close to each other. FAM is a feature that permits rapid creation of anatomical maps by movement of a sensor-based catheter throughout the cardiac chamber. Unlike point-by-point electroanatomic mapping, volume data can be collected with FAM (see Fig. 6.1 ).
CARTO-Merge.
The CARTO-Merge Module allows for images from preacquired computed tomography (CT) angiogram or MRI volume data sets to be integrated on the electroanatomic image of the cardiac chamber created with the CARTO system and simultaneously display them within the same coordinate system ( Fig. 6.3 ). This can be very valuable in guiding real-time catheter ablation using the detailed cardiac chamber anatomy acquired from the CT/MRI.
CARTO-Univu.
The CARTO-Univu module permits overlaying of the 3-D anatomic map and catheter visualization on prerecorded x-ray images or cine loops. When proximity of the ablation target to the coronary circulation is a concern, such an overlay of the coronary angiogram allows RF energy application without the need for repeated coronary angiography. It is important to recognize, however, that the fluoroscopy or angiographic images are not gated to the electrocardiogram (ECG) or respiratory cycle, and any shift in of the prerecorded image during the course of the study requires the acquisition of new x-ray images.
CARTO-Sound.
The CARTO-Sound Image Integration Module incorporates the electroanatomic map to a map derived from intracardiac echocardiography (ICE), and allows for 3-D reconstruction of the cardiac chambers using real-time ICE. ICE is performed using a phased-array transducer catheter incorporating a navigation sensor (SoundStar, Biosense Webster) that records individual 90-degree sector image planes of the cardiac chamber of interest, including their location and orientation, to the CARTO workspace. A 3-D volume-rendered image is created by obtaining ECG-gated ICE images of the endocardial surface of the cardiac chamber of interest ( Fig. 6.4 ). Three-second segments of 2-D ICE images are acquired during ECG gating to the P wave during sinus rhythm and to the R wave during AF. Since ICE images are not automatically gated to respiration by the system, images used in the analysis are acquired in the late-expiration to the midexpiration phase. Following optimizing each image by adjusting frequency (5 to 10 MHz) and contrast, the chamber endocardial surfaces are identified (based on differences in the echo intensity of blood and tissue), and their contours are traced automatically, and overwritten by hand as necessary, using the CARTO-Sound software. The contour lines for the chamber of interest are drawn below the border to prevent image bloating. The software then resolves each contour into a series of discrete spatial points, with an interpoint spacing of up to 3 mm (closer spacing on curved contours or at angulations). The CARTO software interpolates these points to create models of the chamber endocardial surface in the CARTO workspace. CARTO-Sound allows for detailed real-time visualization of the cardiac chamber and of its adjacent structures, and elimination of the chamber deformity that often happens with contact mapping.
CARTO-Sound has been successfully utilized to facilitate AF catheter ablation by incorporating a real-time ICE volume map of the left atrium (LA) and pulmonary veins (PVs) with the electroanatomic map, either as a stand-alone tool to guide navigation and ablation or as a facilitator of CT/MRI image integration. In addition, studies have shown the feasibility of using CARTO-Sound to define scar boundaries in the left ventricle (LV; identified on ICE imaging by both by wall thickness and motion) to facilitate substrate mapping and ablation of ischemic VT. Of note, when AF ablation is guided by 3-D ICE-derived images, ablation points fall beyond the 3-D ICE-derived surface contour more often than when guided by FAM or merged 3-D ICE-CT volume rendering.
EnSite NavX Electroanatomic Mapping System
The EnSite NavX system consists of a set of three pairs of skin patches—a system reference patch, ECG electrodes, a display workstation, and a patient interface unit. The reference patch is placed on the patient’s abdomen and serves as the electrical reference for the system.
The EnSite NavX combines catheter location and tracking features of the LocaLisa system (Medtronic, Minneapolis, MN, United States) with the ability to create an anatomical model of the cardiac chamber using only a single conventional EP catheter and skin patches. This mapping modality is based on currents across the thorax, developed as originally applied in the LocaLisa system. In contrast to the NavX system, LocaLisa does not allow the generation of 3-D geometry of the heart cavity because catheters and desired anatomical landmarks are displayed in a Cartesian frame of reference. This technology has undergone substantial additional development in the NavX iteration.
For 3-D navigation, six electrodes (skin patches) are placed on the patient’s skin to create electrical fields along three orthogonal axes (x, y, and z). The patches are placed on both sides of the patient (x-axis), the chest and back (y-axis), and the back of the neck and inner left thigh (z-axis). Analogous to the Frank lead system, the three orthogonal electrode pairs are used to send three independent, alternating, low-power currents of 350 mA at a frequency of 5.7 kHz through the patient’s chest in three orthogonal (x, y, and z) directions, with slightly different frequencies of approximately 30 kHz used for each direction, to form a 3-D transthoracic electrical field with the heart at the center. The absolute range of voltage along each axis varies from each other, depending on the volume and type of tissue subtended between each surface-electrode pair. The voltage gradient is divided by the known applied current to determine the impedance field that has equal unit magnitudes in all three axes. Each level of impedance along each axis corresponds to a specific anatomical location within the thorax. As standard catheter electrodes are maneuvered within the chambers, each catheter electrode senses the corresponding levels of impedance, derived from the measured voltage. The mixture of the 30-kHz signals, recorded from each catheter electrode, is digitally separated to measure the amplitude of each of the three frequency components. The three electrical field strengths are calculated automatically via the difference in amplitudes measured from neighboring electrode pairs with a known interelectrode distance for three or more different spatial orientations of that dipole. Timed with the current delivery, NavX calculates the x-y-z impedance coordinates at each catheter electrode by dividing each of the three amplitudes (V) by the corresponding electrical field strength (V/cm), and expresses them in millimeters to locate the catheters graphically in real time to enable nonfluoroscopic navigation. The NavX system allows real-time visualization of the position and motion of up to 128 electrodes on both ablation and standard catheters positioned elsewhere in the heart ( Fig. 6.5 ). Importantly, the relative positions of the electrodes are calculated by assuming that changes in the recorded field potential are only caused by changes in catheter position. Therefore changes in thoracic impedance can cause the system to “drift.”
The NavX system also allows for rapid creation of detailed models of cardiac anatomy. Sequential positioning of a catheter at multiple sites along the endocardial surface of a specific chamber establishes that chamber’s geometry. The system automatically acquires points from a nominated electrode at a rate of 96 points/s. Chamber geometry is created by several thousand points. The algorithm defines the surface by using the most distant points in any given angle from the geometry center, which can be chosen by the operator or defined by the system. In addition, the operator is able to specify fixed points that represent contact points during geometry acquisition; the algorithm that calculates the surface cannot eliminate these points. In addition to mapping at specific points, there is additional interpolation, providing a smooth surface onto which activation voltages and times can be registered (see Fig. 6.5 ). To control for variations related to the cardiac cycle, data acquisition can be gated to any electrogram. Also, electrode positions are averaged over a few seconds to minimize the effect of cardiac motion. Respiratory compensation is collected just before mapping. The algorithm records the movement that occurs with respiration and correlates it with changes in transthoracic impedance to filter low-frequency cardiac shift associated with the breathing cycle.
After creating chamber geometry, a scaling algorithm (field scaling) is applied to compensate for variations in impedance between the heart chambers and venous structures, which can otherwise result in a distortion of the x-y-z coordinates when a “roving” catheter is maneuvered among the differing regions of impedance ( Fig. 6.6 ). Field scaling is based on the measured interelectrode spacing for all locations within the geometry. Adjustments to the local strength of the navigation fields are made so that the computed catheter electrode positions match the known interelectrode spacing of the catheters used to create the geometry.
The NavX system works with most manufacturers’ ablation catheters, RF generators, or cryogenerators. Sites of ablation energy application can be tagged, thus facilitating the creation of lines of block with considerable accuracy by serial placement of energy applications and allowing verification of the continuity of the ablation line.
The EnSite Fusion iteration has the capability to integrate images from a preacquired CT/MRI scan on the real-time electroanatomic image the cardiac chamber created with the NavX system to facilitate anatomically based ablation procedures. To allow local adjustment of the EnSite System model, the registration module comes with Dynamic Registration. The system has the ability to mold the created geometry dynamically into the CT/MRI image (see later discussion).
The EnSite Precision iteration adds magnetic navigation capability. Magnetic points are collected with several new magnet-enabled catheters. Magnetic-field stability reduces the effects of “impedance drift,” corrects impedance distortion, and helps optimize catheter navigation and creation of a precise, accurate geometry model.
Rhythmia Electroanatomic Mapping System
Rhythmia is a novel 3-D electroanatomic mapping platform that is paired to a mini-basket array catheter with 64 mini-electrodes (Orion, Boston Scientific) and is capable of generating ultra–high-density electroanatomic maps. This system uses a hybrid location technology that combines impedance and magnetic location. The magnetic field is generated by a localization generator positioned under the patient’s table and is capable of locating catheters with magnetic sensors. The impedance location technology is used to track catheters that are not equipped with a magnetic sensor. The system then maps the impedance field measurements to the magnetic location coordinates and creates an impedance field map. This map is used to enhance the accuracy of the impedance location.
Orion is an 8.5 Fr bidirectional deflectable catheter with a mini-basket electrode array containing eight splines, each spline containing eight small electrodes ( Fig. 6.7 ). The surface area of each electrode is 0.4 mm 2 , and the interelectrode spacing is 2.5 mm (measured from center to center). The basket can be deployed into a spherical configuration through mechanical flexion of the splines to varying diameter (minimum 3 mm, nominal 18 mm, maximum 22 mm, when measured at its equator). The location of each electrode is determined using a combination of magnetic sensor located at the tip of the catheter and impedance sensing at each of the electrodes. A flushing mechanism is present at the catheter tip to prevent thrombus formation. Other catheters are tracked by an impedance-based system.
Two data acquisition modes are available with the Orion catheter: continuous and manual. In the continuous data acquisition mode, operator-defined criteria for accepting cardiac beats are applied for automated map construction during uninterrupted movement of the catheter, without immediate input from the operator. The electrograms from collected beats are automatically annotated by the system. In the manual data acquisition mode, the operator collects data in an “area-by-area” manner, and manually accepts and annotates selected points.
During continuous, automated data acquisition, points are accepted only if they meet user predefined acceptance criteria such as cycle length (CL) stability, stable timing difference between two reference electrodes, respiration gating (the respiratory cycle is tracked by measuring impedance change across the chest), stable catheter location, stability of catheter signal compared with adjacent points, and morphology matching. The automated algorithms filter out points with discrepancy in comparison to those of close proximity. Far-field components are reduced by combining unipolar and bipolar electrograms.
The setup for the mapping window is automatic. The system calculates the mean CL of the rhythm over 10 seconds and consequently sets 100% of the CL equally before and after the timing reference electrode (usually one of the coronary sinus [CS] electrograms, or the QRS interval of one of the surface ECG leads for ventricular rhythms). For annotation of the local activation time of each acquired electrogram, the system combines unipolar (maximum negative dV/dt) and bipolar (maximum amplitude) electrogram. For electrograms with multiple potentials, the system selects the potential that best matches the timing of electrograms in the surrounding area. The very small size of the electrodes on the Orion catheter minimizes far-field signals and background noise, and allows accurate detection of very small amplitude signals.
The anatomical shell is gradually constructed with every accepted beat based on the location of the outermost electrodes of the basket catheter. Inclusion or exclusion of electrograms into the group of surface electrograms is based on the distance from the surface geometry (1 to 5 mm), which can be set by the operator. The system will automatically delete inner electrogram points as more signals are recorded from a spatially outside location.
All electrograms are stored for later review. Maps can be edited by the operator after data acquisition is complete. The software allows for visualization of the electrogram associated with each anatomic point, facilitating re-annotation or removal of inaccurate data. By selecting individual electrograms with a virtual roving probe, it is possible to determine and mark a region of interest (e.g., His bundle [HB] region). In addition, a cutout of anatomical structures such as the tricuspid annulus can be performed based on the corresponding electrograms in review mode ( Fig. 6.8 ).
Electroanatomic Activation Mapping
Anatomical Reference
Once the mapping catheter (or any electroanatomically tracked electrode) is placed inside the heart, its location can be determined in relation to a fixed anatomical reference. This reference catheter is positioned inside the heart or on the body surface, and its location must remain stable throughout the procedure to prevent distortion of the electroanatomic map. The movement of the mapping catheter is then tracked relative to the position of this reference. An intracardiac reference catheter has the advantage of moving with the patient’s body and with the heart during the phases of respiration. However, the intracardiac reference catheter can change its position during the course of the procedure, especially during manipulation of the other catheters.
In the CARTO mapping system, locations of magnetically enabled catheters are displayed in relation to the fixed magnetic field sensors placed under the patient. The CARTO system continuously calculates the position of the mapping catheter in relation to this array of sensors, thus solving the problem of any possible motion artifacts. The movement of the ablation catheter is then tracked relative to the position of this reference. Slight movement of the patient relative to the location reference pad may distort the map; significant patient movement or dislocation of the location pad can lead to uncorrectable map shifts.
In the NavX system, the 3-D localization of all EP catheters is based on an impedance gradient-calculation system in relation to a reference electrode placed on the patient’s body or inside the heart (e.g., CS catheter). Since the reference electrodes and catheters are placed either on the patient’s skin or in the patient’s cardiac chambers, they move simultaneously with the patient, preventing map shifts and rendering the NavX largely insensitive to potential patient movements. The Rhythmia system also uses an anatomical sensor attached to patient’s back.
The Rhythmia mapping system uses a hybrid location technology that combines impedance location with magnetic location technology and uses two location references, one for each localization technology. The magnetic technology uses a location reference attached to the patient’s back, while the impedance technology uses a stationary intracardiac electrode (e.g., a CS electrode) selected by the user.
Electrical Reference
The electrical reference is the fiducial marker on which the entire mapping procedure is based. The timing of the fiducial point is used to determine the activation timing in the mapping catheter in relation to the acquired points and to ensure collection of data during the same part of the cardiac cycle. It is therefore vital to the performance of the system. All the local activation timing information recorded by the mapping catheter at different anatomical locations during mapping (displayed on the completed 3-D map) is relative to this fiducial point, with the acquisition gated so that each point is acquired during the same part of the cardiac electrical signal. It is important that the rhythm being mapped is monomorphic and the fiducial point is reproducible at each sampled site.
The fiducial point is defined by the user by assigning a reference channel and an annotation criterion. The system has a great deal of flexibility in terms of choosing the reference electrogram and gating locations. Any surface ECG lead or intracardiac electrogram in bipolar or unipolar mode can serve as a reference electrogram. For the purpose of stability when intracardiac electrograms are selected, CS electrograms are usually chosen for mapping supraventricular rhythms, and a right ventricle (RV) electrode or a surface ECG lead is commonly chosen as the electrical reference during mapping ventricular rhythms. Care must be taken to ensure the reference electrogram is distinct and stable, and that automatic sensing of the reference is reproducible and is not subject to oversensing in the case of annular electrograms (e.g., oversensing of a ventricular electrogram on the CS reference electrode during mapping an atrial rhythm). Any component of the reference electrogram may be chosen for a timing reference, including maximum (peak positive) deflection, minimum (peak negative) deflection, maximum upslope (dV/dt), or maximum downslope.
Window of Interest
Defining an electrical window of interest is a crucial aspect in ensuring the accuracy of the initial map coordinates. The window of interest is defined as the time interval relative to the fiducial point during which the local activation time is determined ( Fig. 6.9 ). Within this window, activation is considered early or late relative to the reference. Timing and voltage of electrograms falling outside this window are excluded from the map and cannot be tagged without altering the window. The total length of the window of interest should not exceed the tachycardia cycle length (TCL; generally 10 or 20 milliseconds less than the TCL). The boundaries are set relative to the reference electrogram. Thus the window is defined by two intervals—one extending before the reference electrogram and the other after it. For focal tachycardias, the window of interest is usually selected so that it starts about 50 milliseconds before the onset of the tachycardia complex on the surface ECG (P wave or QRS), regardless of the timing of the electrical reference. For macroreentrant tachycardias, the sensing window should approximate the TCL, and designating activation times in a circuit as early or late is arbitrary. If the activation window spans more than one tachycardia cycle, the resulting map can be ambiguous, lack coherency, and give rise to a spurious pattern of adjacent regions of early and late activation ( Figs. 6.9 and 6.10 ). In theory, a shift in the window or electrical reference would not change a macroreentrant circuit but only result in a phase shift of the map ( Fig. 6.11 ).
Local Activation Time
Once the reference electrogram, anatomical reference, and window of interest have been chosen, the mapping catheter is moved from point to point along the endocardial surface of the cardiac chamber being mapped. These points can be acquired in a unipolar or bipolar configuration. These electrograms are analyzed using the principles of activation mapping discussed in Chapter 5 . The local activation time at each sampled site is calculated as the time interval between the fiducial point on the reference electrogram and the corresponding local activation determined from the unipolar or bipolar local electrogram recorded from that site.
In general, the local activation time at each site is determined from the intracardiac bipolar electrogram and is measured in relation to the fixed reference electrogram. For bipolar electrograms, the initial peak of a filtered (30 to 300 Hz) bipolar signal coincides with depolarization beneath the recording electrode and appears to correlate most consistently with local activation time, corresponding to the maximal negative dV/dt of the unipolar recording. However, in the setting of complex multicomponent or fractionated bipolar electrograms, the determination of local activation time becomes challenging, and the decision about which activation time is most appropriate needs to be made in the context of the particular rhythm being mapped. Therefore, during mapping procedures, the onset (rather than the peak or nadir) of a high frequency component of the local bipolar electrogram often is used because it is easier to determine reproducibly, especially when measuring heavily fractionated, low-amplitude local electrograms. The onset of the bipolar electrogram likely precedes the maximal −dV/dt in unipolar electrogram by 15 to 30 milliseconds.
For filtered and unfiltered unipolar electrograms, the maximum negative slope (i.e., maximum change in potential, dV/dt max ) of the signal coincides best with the arrival of the depolarization wavefront directly beneath the electrode.
Contemporary mapping systems offer automatic data acquisition and timing annotation of accepted points. Using these automated algorithms, timing of local activation is annotated at the point of maximum amplitude of the bipolar signal or the maximum negative dV/dt of the unipolar signal. For electrograms with multiple potentials, the system selects the potential that best matches the timing of electrograms in the surrounding area. When automated timing annotation is used, it is important to utilize the same parameters for the timing of local activation when additional points are acquired manually or during the editing of automatically acquired data.
Data Acquisition
Following selection of the reference electrogram, positioning of the anatomical reference, and determination of the window of interest, the mapping catheter is positioned in the cardiac chamber of interest. The CARTO and Rhythmia systems require the use of proprietary catheters with a location sensor to collect mapping data. In contrast, NavX-guided procedures are performed using the same catheter setup as conventional approaches. Any electrode can be used to gather data, create static isochronal and voltage maps, and perform ablation procedures. Standard EP catheters of choice are introduced into the heart; up to 128 electrodes can be viewed simultaneously. The NavX system can locate the position of the catheters from the moment that they are inserted in the vein. Therefore all catheters can be navigated to the heart under guidance of the EnSite NavX system, and the use of fluoroscopy can be minimized for preliminary catheter positioning. However, interrupted fluoroscopy must be used repeatedly when an obstacle to catheter advancement is encountered. Once in the heart, one intracardiac catheter is used as a reference for geometry reconstruction. A shadow (to record original position) is placed over this catheter to recognize displacement during the procedure, in which case the catheter can be returned easily to its original location under the guidance of NavX. A shadow can also be displayed on each of the other catheters to record that catheter’s exact spatial position at some particular time (e.g., where PV potentials are best seen).
The mapping catheter is initially positioned (using fluoroscopy) at known anatomical points that serve as landmarks in the chamber of interest for the electroanatomic map. For example, to map the right atrium (RA), points such as the superior vena cava (SVC), inferior vena cava (IVC), HB, tricuspid annulus, and CS os are marked. The catheter is then advanced slowly around the chamber walls to sample multiple points along the endocardium, thus sequentially acquiring the location of its tip together with the local electrogram.
Points are selected only when the catheter is in stable contact with the wall. The system continuously monitors the quality of catheter-tissue contact and local activation time stability to ensure the validity and reproducibility of each local measurement. The stability of the catheter and contact is evaluated at every site by examining the following: (1) local activation time stability, defined as a difference between the local activation calculated from two consecutive beats of less than 2 milliseconds; (2) location stability, defined as a distance between two consecutive gated locations of less than 2 mm; (3) morphological super-impositioning of the intracardiac electrogram recorded on two consecutive beats; and (4) CL stability, defined as the difference between the CL of the last beat and the median CL during the procedure. Furthermore, contact force measurement at the tip of the mapping electrode (when available) can help optimize electrode-tissue contact and improve mapping accuracy.
Contemporary mapping systems enable automated data acquisition from the designated mapping catheter. The algorithm automatically accepts and annotates activation times for points that fulfill an operator-defined set of acceptance criteria. Beats are included in the map based on CL stability, relative timing of reference electrograms, electrode location stability, and respiratory gating, among other optional criteria. These algorithms help streamline the mapping and validation process and reduce overall mapping and manual annotation time.
Because respiratory excursions can cause significant shifts in apparent catheter location, respiratory compensation is collected just before mapping to filter low-frequency cardiac shift associated with the breathing cycle. The current iteration of the CARTO mapping system allows for automatic gating to the respiratory cycle.
Each selected point is tagged on the 3-D map. Lines of block (manifest as double potentials) are tagged for easy identification because they can serve as boundaries for the subsequent design of ablation strategies. Electrically silent areas (defined as having an endocardial potential amplitude less than 0.05 mV [the baseline noise in the mapping system], and the absence of capture at 20 mA) and surgically related scars are tagged as “scar” and therefore appear in gray on the 3-D maps and are not assigned an activation time ( see Figs. 14.1 and 14.2 ). The map can also be used to catalog sites at which pacing maneuvers are performed during assessment of the tachycardia.
Sampling the location of the catheter together with the local electrogram is performed from multiple endocardial sites. Catheters other than the ablation catheter, such as the multipolar Lasso or Penta-Ray, can further enhance the collection of points, increase the mapping speed, and improve map resolution. The points sampled are connected by lines to form several adjoining triangles in a global model of the chamber. Next, gated electrograms are used to create an activation map, which is superimposed on the anatomical model. The acquired local activation times are then color-coded and superimposed on the anatomical map, with red indicating early-activated sites, blue and purple indicating late-activated areas, and yellow and green indicating intermediate activation times (see Figs. 6.5 and 6.11 ). Between these points, the mapping systems assign an activation time over the area around each acquired point, and the adjoining triangles are colored with these interpolated values. The size of this area is determined by setting the triangle “fill threshold” or “interpolation threshold,” which is adjustable. If the points are spaced widely apart (beyond the fill threshold), no interpolation is done. As each new site is acquired, the reconstruction is updated in real time to create a 3-D chamber geometry color progressively encoded with activation time.
Sampling an adequate number of homogeneously distributed points is necessary. If inadequate numbers of points are taken and the fill threshold allows interpolation over a large area, the colors assigned to the poorly mapped areas will not be representative of the actual conduction pattern and activation timing. Thus bystander sites can be mistakenly identified as part of a reentrant circuit, and lines of conduction block can be missed. In addition, low-resolution mapping can obscure other interesting phenomena, such as the second loop of a dual-loop tachycardia. Some arrhythmias, such as complex reentrant circuits, require more than 80 to 100 points to obtain adequate resolution. Other tachycardias can be mapped with fewer points, including focal tachycardias and some less complex reentrant arrhythmias, such as isthmus-dependent AFL. The use of multielectrode mapping catheters can improve map resolution and expedite the mapping process.
It is also important to identify areas of scar or central obstacles to conduction; failure to do so can confuse an electroanatomic map because interpolation of activation through areas of conduction block can give the appearance of wavefront propagation through, rather than around, those obstacles. This occurrence precludes identification of a critical isthmus in reentrant arrhythmias to target for ablation. A line of conduction block can be inferred if there are adjacent regions with wavefront propagation in opposite directions separated by a line of double potentials or dense isochrones.
The electroanatomic model, which can be viewed in a single view or in multiple views simultaneously and freely rotated in any direction, forms a reliable road map for navigation of the ablation catheter. Any portion of the chamber can be seen in relation to the catheter tip in real time, and points of interest can easily be revisited even without fluoroscopy. The electroanatomic maps can be presented in two or three dimensions as activation, isochronal, propagation, or voltage maps.
Activation Map
During mapping, the electrogram obtained at a given site is stored and the activation time catalogued as compared with the designated reference electrogram. The accrued points in the map are assigned to an isochronal color scale based on their respective activation times. The activation maps display the local activation time, color-coded and overlaid on the reconstructed 3-D geometry ( see Figs. 11.21 and 12.14 ). Each color shift represents a temporal fraction of the entire TCL. Activation mapping is performed to define the activation sequence. A reasonable number of points homogeneously distributed in the chamber of interest must be recorded. The selected points of local activation time are color-coded.
The electroanatomic maps of focal tachycardias demonstrate radial spreading of activation, from the earliest local activation site in all directions, and in these cases, activation time is markedly shorter than TCL ( Fig. 6.2 ). In contrast, a continuous progression of colors around the mapped chamber, with close proximity of earliest and latest local activation (“early-meets-late” zone), suggests the presence of a macroreentrant tachycardia (see Fig. 6.11 ). Importantly, the early-meets-late zone should not be used as an indicator of the location of the critical isthmus of the macroreentrant circuit (which is the usual ablation target). Rather, it is merely a function of where the offset and onset of the window of interest are defined relative to the timing of the selected reference electrogram. As noted previously, the early-meets-late zone can shift in location and timing in response to shifts in the window of interest or electrical reference (see Figs. 6.8 and 6.11 ).
It is also important to recognize that a focal tachycardia can produce an electroanatomic activation map that mimics reentry when anatomical or functional barriers to conduction close to the site of origin of the tachycardia (such as anisotropic conduction, scars, incisions, or prior ablation lines) cause the delay of wavefront propagation to span the entire TCL and arrive late to sites close to the focus of the tachycardia. For example, a focal AT originating from the coronary sinus ostium (CS os) in a patient with prior cavotricuspid isthmus (CTI) ablation can produce an electroanatomic map mimicking that of peritricuspid macroreentry (counterclockwise typical AFL; Fig. 6.12 ). When the “early-meets-late zone” is observed in an activation map that does not span the entire TCL, inadequate mapping should be suspected and more detailed mapping should be performed before concluding macroreentry as the mechanism of the tachycardia.
On the other hand, a macroreentrant tachycardia can produce an electroanatomic activation map that mimics a focal mechanism. If an insufficient number of activation points is obtained, it may be falsely concluded through the interpolation of activation times that the wavefront propagates from a focal source ( see Fig. 13.11 ). This is frequently encountered when the macroreentrant tachycardia originates from the chamber contralateral to the one being mapped. In the latter situation, the activation map will localize the site of the earliest local activation to the earliest breakthrough of conduction into the chamber being mapped. Notably this breakthrough location, although showing the earliest recorded activation timing relative to the intracardiac electrical reference, may not be presystolic (as compared with the onset of the P wave or QRS on the surface ECG) and, hence, cannot be the site of origin of a focal tachycardia. This provides an additional clue to help interpret the activation map and should prompt more detailed mapping. Similarly, a focal pattern can be observed during endocardial mapping when significant parts of the macroreentry circuits are located intramurally or epicardially.
Isochronal Map
The electroanatomic mapping system can generate isochrones of electrical activity as color-coded static maps. The isochronal map depicts all the points with an activation time within a specific range (e.g., 10 milliseconds) with the same color. Depending on conduction velocity, each color layer is of variable width; isochrones are narrow in areas of slow conduction and broad in areas of fast conduction. Displaying information as an isochronal map helps demonstrate the direction of wavefront propagation, which is perpendicular to the isochronal lines, along the vector of the color changes. Furthermore, isochronal crowding (i.e., multiple colors evident over a small distance) indicating a conduction velocity of 0.033 cm/msec (slower than 0.05 cm/msec) is considered a zone of slow conduction, whereas a collision of two wavefronts traveling in different directions separated temporally by 50 milliseconds is defined as a region of local block. Spontaneous zones of block or slow conduction (less than 0.033 cm/msec) may have a major role in the stabilization of certain arrhythmias.
Propagation Map
Activation mapping data can be displayed in a color-coded animated dynamic map of activation wavefront (propagation map; see Figs. 11.21 and 12.13 ). Propagation of electrical activation is visualized superimposed on the 3-D anatomical reconstruction of the cardiac chamber in relation to the anatomical landmarks and barriers. Analysis of the propagation map can allow estimation of the conduction velocity along the reentrant circuit and identification of areas of slow conduction.
EnSite Precision enables the visualization of propagation of the activation wavefront over voltage maps, which better illustrate activation patterns in relation to regions of electrical scar ( Fig. 6.13 ).
Entrainment Map
A graphical representation of entrainment mapping can be constructed by plotting values of the differences between the postpacing intervals (PPIs) and the TCLs (PPI–TCL) on the electroanatomic mapping system to generate color-coded 3-D entrainment maps ( Fig. 6.14 ). This approach can potentially help accurately determine and visualize the 3-D location of the entire reentrant circuit, even though the area of slow conduction of the tachycardia is not specified. Because none of the electroanatomic mapping systems contain an algorithm for color-coding of entrainment information, the modus for activation mapping is altered manually. At each 3-D location of the catheter tip stored on the electroanatomic mapping system, entrainment stimulation is performed, and the difference between PPI and TCL is calculated and associated with that site on the electroanatomic mapping system (as if it were an “activation time”). For that, the local electrogram stored at the 3-D location is completely disregarded. The annotation marker is manually moved into a position where the numeric timing information equals the entrainment information (PPI–TCL). That timing information then is displayed in a color-coded fashion as if it were activation time, but instead it represents information on the length of the entrainment return cycle. With the color range, red represents points closest to the reentrant circuit (i.e., sites with smaller PPI–TCL differences, approaching 0, signifying their inclusion in the reentrant circuit) and purple represents points far away from the circuit (i.e., sites with the largest PPI–TCL differences).
Color-coded 3-D entrainment mapping allows determination of the full active reentrant circuit (vs. passively activated regions of the chamber) and the obstacle around which the tachycardia is circulating, and it provides very useful information on the location of potential ablation sites (see Fig. 6.14 ). However, ablation will not terminate reentry at all these sites. (Just as, although the circuit in orthodromic supraventricular tachycardia includes the ventricle, ablation at one or two sites in that ventricle will not eliminate reentry.) The final choice is determined by the location of anatomical barriers and width of putative isthmuses, so that strategic ablation lines, mainly connecting anatomical barriers, can be applied to transect the circuit and treat the arrhythmia.
Limitations of Electroanatomic Activation Mapping
Although 3-D mapping systems with image integration have been widely adopted for ablation procedures, many of their theoretical benefits remain to be proven. Therefore these systems should remain just one type among the tools facilitating complex catheter ablation procedures and should not distract the electrophysiologist from established EP principles and endpoints.
The sequential data acquisition required for map creation remains very time-consuming because the process of creation of an electroanatomic map requires tagging many points, depending on the spatial details needed to analyze a given arrhythmia. Because the acquired data are not coherent in time, multiple beats are required, and stable, sustained, or frequently repetitive arrhythmia is usually needed for creation of the activation map. Given that these points do not provide real-time, constantly updated information, more time may be needed for making new maps to see a current endocardial activation sequence, detect a change in arrhythmia, or fully visualize multiple tachycardias. In addition, rapidly changing or transient arrhythmias are not easily recorded and may be mapped only if significant substrate abnormalities are present. For macroreentrant tachycardias, variation of the TCL by more than 10% can prevent complete understanding of a circuit, and it decreases the confidence in the electroanatomic activation map. Single premature ventricular complexes (PVCs) or premature atrial complexes (PACs) or nonsustained events may be mapped, although at the expense of an appreciable amount of time. The use of multielectrode catheters for data acquisition helps address many of these issues.
One difficulty with current methods is that incorrect assignment of activation for a few electrograms can invalidate the entire activation map, and manual adjustment is often required to achieve the optimal representation. This is the major drawback of mapping with multipolar electrode catheters; although data from a large number of sites can be acquired quickly, unless all electrograms are adjudicated to ensure correct designation of activation time by the mapping system, the map may be very misleading. In addition, data interpolation between mapped points is used to improve the quality of the display; however, areas of unmapped myocardium are then assigned simple estimates of timing and voltage information that may not be accurate.
If highly fractionated and wide potentials are present, it can be difficult to assign an activation time. In some macroreentrant circuits, much of the TCL is occupied by fractionated low-amplitude potentials. Furthermore, the assignment of a single time value to a multicomponent electrogram does not represent the quality of the electrogram and dismisses important information about the potential role of the recorded potential in the arrhythmia circuit. The subjective selection of an individual local potential within a multicomponent electrogram can drastically alter a propagation map. If these potentials are dismissed or assigned relatively late activation times, a macroreentrant tachycardia may mimic a focal arrhythmia, and it will appear as if substantially less than 90% of the TCL is mapped.
Electroanatomic Voltage Mapping
Voltage mapping is performed to delineate the region of electrical scar that can harbor the arrhythmogenic substrate or can potentially serve as a boundary for the subsequent design of ablation strategies. This can be of significant value in the setting of unstable or unsustainable tachycardias, especially scar-related VT. Substrate mapping helps identify the VT substrate and facilitates ablation of multiple VTs, pleomorphic VTs, and VTs that are unmappable because of hemodynamic instability or poor inducibility. Substrate mapping is also of value even in well-tolerated VTs because it can help focus activation and entrainment mapping efforts on a small region harboring the VT substrate, and therefore help minimize the duration during which the patient is actually in VT. In addition, superimposition of the voltage map on the activation map can help focus auditing of the activation map to areas where low amplitude potentials are recorded.
Bipolar voltage mapping has been correlated with dense scar defined by histopathology and cardiac MRI. Electrical scar is defined by low amplitude of local electrograms and tissue inexcitability during high-output pacing. Although the true range of normal electrogram amplitude is often difficult to define, endocardial ventricular bipolar electrogram amplitude less than 1.5 mV has been accepted as an abnormally low voltage, with a cutoff of 0.5 mV as the signal amplitude that best defines the anatomical region of dense scar ( Table 6.1 ). A pacing threshold greater than 10 mA has been used to define inexcitable scar, provided electrode-tissue contact is adequate. For the atrium, endocardial bipolar potentials with an amplitude of 0.5 mV or less are typically considered abnormal and termed low voltage areas ( eFig. 6.1 ). Silent areas (scars) are defined as having an atrial bipolar potential amplitude of less than 0.05 mV and the absence of atrial capture at 20 mA.
Electrogram Amplitude | Low Voltage | Dense Scar |
---|---|---|
RV and LV endocardial bipolar | <1.5 mV | <0.5 mV |
RV and LV epicardial bipolar | <1.0 mV | <0.5 mV |
LV endocardial unipolar | <8.3 mV | <7.0 mV |
RV endocardial unipolar | <5.5 mV | <3.5 mV |
RA and LA endocardial bipolar | <0.5 mV | <0.05 mV |
A more rigid voltage cutoff criterion is used when analyzing bipolar signals on the ventricular epicardium to limit the influence of epicardial fat and coronary vasculature (see Table 6.1 ). As epicardial fat overlying normal myocardium insulates the underlying tissue, attenuated low-amplitude signals can be mistaken for abnormal myocardial tissue. Normal epicardial electrogram amplitude is defined as greater than 1.0 mV. Dense scar is defined as confluent areas with bipolar electrogram amplitude less than 0.5 mV, and border zone in regions with bipolar electrogram amplitude between 0.5 and 1.0 mV. Because epicardial fat may decrease signal amplitude, low-voltage areas during epicardial mapping should also show abnormal electrogram configuration.
A limitation of bipolar recordings is that they have a limited field of view such that the amplitude of the bipolar electrogram is primarily driven by local tissue activity, while far-field activity is subtracted out. Therefore, although voltage properties of the endocardium are well-represented in the bipolar signal, intramural or epicardial scar that can potentially harbor the arrhythmogenic substrate can be missed by purely endocardial bipolar voltage mapping. In contrast, unipolar electrograms reflect the voltage difference between the exploring electrode in contact with myocardium and a second electrode that is distant from the heart (usually Wilson’s central terminal). Thus the unipolar electrode has a wide field of view, and unipolar electrogram amplitude primarily represents more remote, far-field tissue depolarization. Therefore unipolar voltage mapping has recently been proposed to improve myocardial sensing with a wider field of view to detect the presence of midmyocardial and epicardial scar. A voltage cutoff of 8.3 mV is used to distinguish normal from abnormal LV unipolar endocardial electrogram amplitude ( eFig. 6.2 ). A lower cutoff value of less than 5.5 mV defined normal unipolar voltage for the thinner free wall of the RV ( see Fig. 25.4 ).
Electroanatomic voltage mapping can be performed during sinus, paced, or any other rhythm. The voltage map displays the peak-to-peak amplitude of the electrogram within the sampling time window at each site and is measured automatically by the mapping system. This value is color-coded and superimposed on the anatomical model (see eFig. 6.2 ). The gain on the 3-D color display allows the user to concentrate on a narrow or wide range of potentials. By diminishing the color scale, larger amplitude signals are eliminated.
Embedded within or between areas of dense fibrosis, isolated bundles of viable myocardium (called conducting channels ) can potentially form protected the diastolic isthmuses necessary to support the arrhythmia circuit. Conduction through these bundles is typically slow and anisotropic, resulting in low-amplitude, multipotential, fractionated bipolar electrograms. Abnormal low-voltage electrograms can be recorded throughout extensive areas of scar that are not sufficiently specific for the components of the reentrant circuit. Thus the identification of the conducting channels within the low voltage zones helps refine the area that potentially supports the tachycardia circuit. Conducting channels can be identified on the electroanatomic voltage map as corridors of voltage preservation (voltage channels) within denser regions of scar, or as corridors between a dense scar and a valvular annulus. Careful step-by-step manual adjustment of voltage upper and lower limits on the color-coded electroanatomic voltage map (scar thresholding) can help maximize the color contrast between adjacent myocardium with different electrogram voltage levels within the 0.5-mV scar and thus unmask channels of viable myocardium within a dense scar ( see eFig. 22.14 and Fig. 22.28 ).
Pacing provides complementary information to electrogram amplitude; only 2% of sites with amplitude more than 0.5 mV have a pacing threshold more than 10 mA, whereas a substantial number of very low amplitude sites have high pacing thresholds, and many sites in reentry circuit isthmuses have very low amplitudes. A dense scar is defined by the lack of electrical excitability during high-output pacing.
Factors Influencing Voltage Mapping Resolution
Bipolar electrogram amplitude is influenced by multiple variables that can affect the accuracy and resolution of the voltage map. These include the electrode size, interelectrode distance, conduction velocity between the bipolar electrodes, vector of activation, and the angle at which the electrode engages the tissue, and signal filtering, among others.
Electrode size.
The resolution of voltage mapping is influenced electrode size and interelectrode spacing. The spatial resolution of the standard mapping catheter is limited due to the large electrode surface area and wide interelectrode spacing. These catheters record signals produced by relatively large tissue mass and, hence, are more likely to exhibit larger bipolar electrogram amplitudes. Furthermore, low-amplitude signals produced by smaller mass of viable tissue can be lost when recorded with large electrodes. Therefore, while voltage mapping likely identifies large unexcitable areas of scar, small strands of fibrosis, which could harbor the arrhythmogenic substrate, may escape detection amidst the background of high-amplitude far-field signals. Similarly, small strands of surviving myocardium within an area of dense scar may not be detected during voltage mapping.
Smaller electrodes with closer interelectrode spacing record signals from smaller tissue mass and are subjected to less signal averaging and cancellation effects. As a result, data acquisition with smaller electrodes allows for the accurate detection of very small amplitude signals while limiting the effects of far-field signals and background noise. This can be of particular advantage in the low-voltage zones and areas of heterogeneous scar distribution, where the increased mapping resolution offered by the multielectrode catheters allows identifying surviving myocardial bundles channels, otherwise considered dense scar by standard linear catheters ( Fig. 6.15 ).
It is important to note that a minimal electrogram amplitude to identify an unexcitable scar has not yet been strictly defined. As different catheters with various electrode sizes and interelectrode spacings are becoming available, individualized validation is required, and catheter-specific thresholds are needed to improve scar characterization.
Vector of activation.
The vector of propagation of the activation wavefront in relation to the two recording electrodes, and orientation of the recording electrode relative to the tissue, influences the degree of signal cancellation and therefore the resultant bipolar signal amplitude.
In multiple studies, significant differences in bipolar and unipolar low-voltage characterization of ventricular scar were frequently observed by varying the wavefront of ventricular activation. Activation within viable neighboring tissue can allow for greater variability in myocardial activation, resulting in wavefront fusion (additive to electrogram) and cancellation (subtractive from electrogram). Furthermore, local conduction delay or block and uncoupling between near- and far-field signals can potentially account for these observations. Mismatches between low bipolar voltage regions appear to occur most frequently in areas with predominantly mixed scar tissue (areas with electrogram amplitudes in the range of 0.5 to 1.5 mV) and in septal regions. Dense scar appears to be less sensitive to wavefront changes compared with mixed scars, likely due to lesser available mass of normal far-field myocardium to contribute to the electrogram signal within the field of view of the mapping catheter. Therefore voltage mapping during more than one activation sequence (e.g., during normal sinus rhythm [NSR] and ventricular pacing) can potentially increase the sensitivity to detect arrhythmogenic substrate.
Tissue contact.
Voltage mapping relies heavily on consistent catheter contact. If catheter contact is suboptimal and falsely low voltage measurements are recorded, the voltage map will erroneously suggest a scar. The use of ICE and contact force sensors can help ensure adequate catheter contact.
Mapping density.
Low mapping density is associated with the significant interpolation of data between sampled points. The use of multielectrode catheters enables rapid high-density voltage mapping through simultaneous multiple-point acquisition, which reduces interpolation of data between points and improves mapping accuracy.
Limitations of Electroanatomic Voltage Mapping
Electrogram amplitude is annotated to the electrogram peak. In regions of scar, far-field signals are frequently of larger amplitude than local electrograms. Therefore automated voltage annotation of the larger far-field electrograms can introduce errors in the voltage map, especially in scar regions ( Fig. 6.16 ). Manual tagging of abnormal potentials or manual annotation of near-field electrogram voltage can help improve the map accuracy, but this can be challenging with high-density point acquisition.
Voltage mapping during NSR depends on the assumption that the arrhythmogenic substrate is limited to fixed myocardial scar and anatomical barriers. It is now well known that functional lines of block (present during tachycardia but not in NSR) play an important role in arrhythmogenesis, and these barriers cannot be detected by substrate mapping performed in NSR. Therefore conducting channels developing during arrhythmias and surrogates of channels and conduction barriers identified by substrate mapping in NSR may not correspond.
Even when conducting channels within the scar area can be identified by voltage mapping, their relationship to the arrhythmia circuit remains to be assessed by other mapping methods (e.g., entrainment mapping). Voltage mapping does not distinguish abnormal bystander areas that are not involved in a tachycardia circuit from clinically relevant channels.
It is also important to recognize that the transmural distribution of the scar may not be reliably represented by voltage mapping from either the endocardial or epicardial surface. In particular, identifying septal or mid-myocardial substrates can be challenging.
High-Resolution Electroanatomic Mapping
Current iterations of electroanatomic mapping systems allow the construction of high-resolution electroanatomic maps through catheters with multiple electrodes. These multielectrode mapping catheters facilitate the creation of high-density maps through simultaneous acquisition of points from multiple closely spaced electrodes. The rapid acquisition of a large quantity of data facilitates the generation of detailed, high-density, high-resolution activation and voltage maps. Further, the use of multielectrode mapping catheters helps expedite the process of data acquisition during electroanatomic mapping and decrease fluoroscopy and procedure times. Automated data acquisition and annotation can further facilitate the mapping process (with the previously noted caveats).
Several multielectrode catheters with varying configurations have been described. The EnSite NavX system can utilize any multielectrode catheter for data acquisition. The multipolar Lasso, PentaRay, and DecaNav catheters (Biosense Webster) are equipped with the electromagnetic sensor and can be used with the CARTO system, allowing for electroanatomical data acquisition. The circular Lasso catheter has 10 or 20 electrodes, each with a surface area of 1.0 mm 2 , recording bipolar electrograms with an interelectrode spacing of 3 mm, and maximal diameter of 25 mm. The star-shaped multielectrode PentaRay is a 7 Fr steerable catheter (180 degrees of unidirectional flexion) with 20 electrodes distributed over five soft, radiating spines (1-mm electrodes separated by 4-4-4 or 2-6-2 mm edge-to-edge interelectrode spacing), thus allowing splaying of the catheter to cover a surface diameter of 3.5 cm (see Fig. 6.1 ; see Fig. 4.2 ). The spines have been given alphabetical nomenclature (A to E), and spines A and B are recognized by radiopaque markers. These multielectrode catheters have smaller electrodes (0.8 mm 2 ) and closer interelectrode spacing (as compared with ablation catheters), which allow for recording bipolar signals from smaller tissue diameters that are less vulnerable to averaging and cancellation effects.
The Rhythmia system utilizes a mini-basket catheter (Orion), which has 64 very small electrodes (0.4 mm 2 ) with interelectrode spacing of 2.5 mm (see Fig. 6.7 ). This catheter allows for the construction of ultra-high resolution activation and voltage maps.
Ripple Mapping
Ripple mapping is a novel visualization technique that displays time-voltage data as dynamic bars on the cardiac surface. Ripple mapping software requires incorporation of a 3-D electroanatomic mapping system (CARTO). Each electrogram component is visualized at its corresponding 3-D coordinate on the CARTO-generated chamber geometry as a dynamic surface bar that varies in height and color according to the electrogram voltage–time relationship that is time-gated to a selected fiduciary reference electrogram. Both positive and negative electrogram deflections are shown protruding outward from the surface. The height of each bar correlates with the voltage amplitude of the electrogram at that time point, without the need for annotation of local activation timing ( Fig. 6.17 ).
When multiple points are collected over an area, adjacent bars move up and down (according to the local voltage) in a sequential fashion (in time relative to a chosen fiducial reference electrogram). As a result, a “ripple” effect is seen as the movement traverses from one bar to the next, creating a “ripple map.” Propagation of activation is visualized by the direction of the “ripple” on the map ( Fig. 6.18 ). Ripple activation maps can be superimposed on a conventional bipolar voltage map, thereby displaying the surface geometry with both voltage and activation simultaneously.
Ripple mapping is designed to overcome some of the limitations of existing electroanatomic activation and voltage mapping. Electroanatomic mapping requires the accurate annotation of local activation time of electrograms within the window of interest. In the region of scar, annotation as a single activation time often is suboptimal, due to the presence of fractionated or multiple late potentials. Incorrect annotation of only a small number of electrograms can invalidate the entire activation map. Furthermore, the assignment of a single time value to an individual local potential within a multicomponent electrogram without indication of signal quality often ignores the information contained within complex fractionated electrograms that can be valuable for the identification of the arrhythmogenic substrate and ablation targets. Voltage mapping can also be challenging in the region of scar. Voltage annotation to the electrogram peak can erroneously incorporate far-field electrograms, which are frequently larger than the local signal. In addition, interpolation of data within unmapped regions can lead to the display of false information.
In contrast, ripple mapping preserves all components of the electrogram. Instead of assigning each point as a single time value to create a color-coded map, ripple mapping preserves and represents all the components of the electrogram (voltage, waveform, and timing) at its corresponding 3-D coordinate as a bar that rises perpendicular to the surface of the cardiac chamber that varies in height according to the underlying voltage amplitude, without the need for manual or automatic annotations of local activation timing or setting a window of interest (see Fig. 6.17 ). As a result, a sequence of small potential changes in a fractionated electrogram can be temporally linked to its adjacent neighbors, and delayed low-amplitude local activation within scar is seen distinct from an initial far-field electrogram occurring in tandem with activation in the surrounding healthy myocardium. Also, the system does not interpolate within unmapped regions; thus interpolation errors are avoided as only “real” data is displayed on the ripple map.
Although data are limited, several small studies demonstrated the potential value ripple mapping in determining activation patterns in both simple and complex cardiac rhythms.
Anatomical Mapping
All the recorded catheter locations are aggregated and used to create a shell (anatomical map) of the cardiac chamber. Modern electroanatomic mapping systems incorporate utilities enabling computer-automated multipoint model creation while the mapping catheter is maneuvered around the anatomical structure (CARTO-3 Fast Anatomic Map Module and EnSite NavX Velocity One-Model Module). A virtual anatomical intracardiac geometry is obtained by moving the catheter in all directions throughout the cardiac chamber of interest, keeping contact with the endocardial wall to outline the structures. Points at the outermost boundaries are used to depict the outer geometry (shell), while points inbound to the outer shell are automatically removed. Acquired activation or voltage mapping points internal or external to the outer shell are included only if they fall within a threshold distance (defined by the user) from the outer surface. A purely anatomical map and catheter navigation capabilities are particularly suitable for ablation of arrhythmias with well-known substrates that can be treated by an anatomically based ablation approach, such as AFL and linear LA ablation for AF.
Electroanatomic maps represent the same anatomical map with an overlay of color-coded electrical data. Acquired activation or voltage mapping points internal or external to the outer shell are included only if they fall within a threshold distance (defined by the user) from the outer surface.
Acquired activation or voltage mapping points internal or external to the outer shell are included only if they fall within a threshold distance (defined by the user) from the outer surface. A purely anatomic map and catheter navigation capabilities are particularly suitable for ablation of arrhythmias with well-known substrates that can be treated by an anatomically based ablation approach, such as AFL and linear LA ablation for AF.
It is important to move the mapping catheter carefully and minimize inconsistency in the contact force on the catheter tip to avoid excessive anatomical distortion and expansion of the virtual image. Such anatomical distortion can misrepresent the local fiducial sites, which should be taken into consideration when mapping and ablation are guided by fast anatomical maps.
Characteristic anatomical landmarks and sites of interest in the cardiac chamber are acquired and tagged. Valvular annuli, thoracic veins, and other structures can be marked and carved out of the electroanatomic map. If a CT reconstruction of the mapped cardiac chamber is available, the image can be visualized on a split screen and used to guide finer anatomical definition with the ablation catheter. On completion, maps can be edited to eliminate “false space” (i.e., geometry with sparse acquired points) and erroneous structure definition. Additional tagging of sites of interest and ablation points can be done during the procedure. Point-to-point activation mapping is carried out to create static isochronal, voltage, and activation maps (see Fig. 6.5 ).
Respiratory compensation is collected just before mapping to filter low-frequency cardiac shift associated with the breathing cycle. The CARTO-3 system enables automatic respiratory-gating for data acquisition through thoracic impedance measurement. With other systems, volume sampling with catheter movement during the exhalation phase can help reduce respiratory artifacts.
With the NavX system, a scaling algorithm (field scaling) can be applied to the completed detailed geometry to compensate for variations in impedance between the heart chambers and venous structures (which can otherwise result in a distortion of the x – y – z coordinates when a “roving” catheter is maneuvered among the regions of differing impedance). Field scaling is based on the measured interelectrode spacing for all locations within the geometry. Adjustments to the local strength of the navigation fields are made so that the computed catheter electrode positions match the known interelectrode spacing of the catheters used to create the geometry.
The CARTO and Rhythmia systems require the use of proprietary catheters with a location sensor to collect mapping data and depict cardiac geometry. In contrast, NavX-guided procedures can be performed using any EP catheter.
Limitations of Anatomical Mapping
Significant anatomical distortions in complex structures can occur with low-density mapping, whereby individual interpolation schemes in the region of curvature do not depict the accurate geometry, especially at areas of exvaginations (e.g., the PVs, atrial appendages). This can be mitigated by (1) the acquisition of a larger number of points (increased density) to reduce the extent of interpolation; (2) the acquisition of a set of points at the critical junctions between the different anatomical structures; and (3) creating geometric shells of these structures in separate maps and then combining them into the main chamber.
In addition, a change in rhythm during the mapping procedure can alter cardiac geometry to the extent that anatomical points acquired during one rhythm cannot be relied on after a change in rhythm ( Fig. 6.19 ). This is relevant during the mapping of PVCs (especially PVCs originating from the RV and those with short coupling intervals), because electrical and spatial information acquired during the arrhythmia can potentially be spatially separated from the same locations when they are assigned during normal rhythm (e.g., at the time of RF delivery after tachycardia termination). Therefore, after termination of the arrhythmia, revisiting the site of early activation tagged during PVCs or tachycardia may not be feasible and can potentially be misleading as a target for ablation. This can be mitigated by annotating the site of interest after tachycardia termination before moving the mapping catheter from its original location.
Furthermore, electroanatomic mapping systems do not provide real-time correlation of catheter position and heart border motion. Therefore localizing the catheter tip against the virtual anatomical shell does not establish catheter tip-tissue contact, and other methods to confirm adequate electrode-tissue contact should be utilized (e.g., pacing and recording data at the catheter tip, intermittent fluoroscopic imaging, ICE, and force contact sensors). In fact, geometric reconstructions of the cardiac chamber during the same procedure can vary depending on the method used. For example, the 3-D ICE-derived LA geometric reconstruction was found to be smaller than reconstructions derived from electroanatomic mapping and merged CT images. During procedures lasting several hours, chamber sizes may change based on the accrual of 1 or more liters of saline infused.
Clinical Implications
Contemporary electroanatomic mapping systems provide the ability to visualize and navigate a complete set of intracardiac catheters in any cardiac chamber for diagnostic and therapeutic applications. Electroanatomic mapping systems integrate 3-D catheter localization with sophisticated complex arrhythmia maps and help associate relevant EP information with the appropriate spatial location in the heart and the ability to study activation patterns with high spatial resolution during tachycardia in relation to normal anatomical structures and areas of scar. This significantly facilitates defining the mechanisms underlying the arrhythmia, making a rapid first-pass distinction between a focal origin and macroreentrant tachycardia, precisely describing macroreentrant circuits and the sequence of activation during the tachycardia, understanding the reentrant circuit in relation to native barriers and surgical scars, identifying all slow-conducting pathways, rapidly visualizing the activation wavefront (propagation maps), and identifying appropriate sites for entrainment and pace mapping.
In addition, these systems provide a highly accurate geometric rendering of the cardiac chamber, with a straightforward geometric display having the capability to determine the 3-D location and orientation of the ablation catheter accurately. The position of the mapping electrode at any instant is readily apparent. The catheter can anatomically and accurately revisit a critically important recording site (e.g., sites with double potentials or those with good pace maps) identified previously during the study, even if the tachycardia is no longer present or inducible and map-guided catheter navigation is no longer possible. This accurate repositioning provides significant advantages over conventional techniques and is of great value in ablation procedures.
Sites of ablation energy application can be tagged, thus facilitating the creation of lines of block with considerable accuracy by serial RF lesion placement and allowing verification of the continuity of the ablation line and anatomical visualization of the remaining gaps, where additional RF applications can be delivered. This is of particular value after incomplete ablations caused by catheter dislocation, especially if these ablations had caused interruption of the target tachycardia. Additional RF applications can be delivered closely around an apparently successful ablation site to ensure elimination of the arrhythmogenic area. It also helps avoid repeated ablations at the same location.
Furthermore, fluoroscopy time and radiation exposure to the operator, the patient, and the laboratory staff can be substantially reduced (or even eliminated entirely) via electroanatomical catheter navigation, and the catheter can be accurately guided to positions removed from fluoroscopic markers.
Choice of Electroanatomic Mapping System
The choice of a specific mapping system for a particular interventional procedure is shaped by the importance of a specific characteristic in the mapping process, as well as the skill and experience of the operator. Advanced mapping systems have a limited role in the ablation of typical AFL, AVNRT, or bypass tracts (BTs), given the high success rate of the conventional approach. However, for more complex arrhythmias, such as AT, AF, and VT, advanced mapping modalities offer a clear advantage. In addition, electroanatomic mapping systems can potentially shorten procedural time, reduce radiation exposure, and enhance the success rate for the ablation of wide spectrum of arrhythmias.
All three systems perform well for mapping of sustained arrhythmias and for substrate-based ablation procedures. On the other hand, mapping nonsustained arrhythmias, PACs, or PVCs can be tedious with each of these three mapping systems because of the need for sequential data acquisition. However, differences in methods of map acquisition between systems may affect procedure length and radiation use. The use of multielectrode mapping catheters (e.g., PentaRay or Orion) can expedite the mapping process.
Nonetheless, it is important for the electrophysiologist to be cognizant of the distinct advantages and shortcomings of each system.
CARTO
Although all three electroanatomic mapping systems demonstrate a high level of intrinsic accuracy, the magnetic field localization technology of CARTO appears to have superior accuracy at point localization performance and fewer problems with interstructure delineation as compared with impedance-based systems. Another advantage of using magnetic fields for catheter localization is that the fields remain stable over time and are unaffected by biological material; hence the localization accuracy of CARTO is less subject to inhomogeneous tissue characteristics. Electrical field distortions seen with EnSite NavX do not occur with CARTO.
A limitation of the CARTO system is the requirement of a special Biosense Webster catheter with a location sensor embedded proximal to its tip. No other catheter types may be used for electroanatomical data acquisition. Furthermore, the magnetic signal necessary for the CARTO system can potentially create interference with other EP laboratory recording systems. Defibrillators and pacemakers are safe with the system, but the magnetic field can prevent device communication with its programmer, and the magnetic field may need to be disabled temporarily to allow device programming. Percutaneous LV assist devices can cause interference and distortion on the mapping system. Magnetic fields used with the Stereotaxis remote magnetic navigation system are not problematic for the CARTO system.
Although CARTO-3 allows current-based visualization of EP catheters without magnetic sensors, the visualization of catheters is confined into a 3-D virtual area (matrix) that can be built only by using a magnetic sensor-equipped manufacturer-specific catheter. Furthermore, the system still cannot process electrical or location data from the nonproprietary catheters (i.e., catheters without magnetic sensors) to build the virtual geometry or for mapping purposes.
Importantly, the coordinates of the magnetic field of CARTO are linked to the table and not the patient’s body. Therefore significant movement of the patient can cause uncorrectable shifts requiring remapping.
EnSite NavX
One of the principal advantages of this system is its open platform. EnSite NavX enables the display in real time up to 128 electrodes simultaneously on multiple EP catheters with almost every commercially available catheter, including pacemaker leads. This system works with most manufacturers’ ablation catheters, RF generators, and cryogenerators. The EnSite System can also be integrated with the Sensei robotic catheter system (Hansen Medical, Mountain View, CA, United States), allowing completely remote catheter navigation.
Also, unlike with the CARTO and Rhythmia, anatomic and electrical data (voltage or activation) can be acquired simultaneously by the EnSite NavX system from multiple poles on all catheters utilized during the study (and not just catheters with magnetic sensors). Data acquisition can be augmented by the addition of a multielectrode array (MEA) for noncontact mapping.
A unique advantage of the EnSite system is that it can locate the position of the catheters from the puncture site to the final destination in the heart. Therefore all catheters can be navigated to the heart under guidance of the EnSite NavX system, and the use of fluoroscopy can be minimized for preliminary catheter positioning. This contrasts with CARTO-3 that enables visualization of EP catheters without magnetic sensors only when positioned within the 3-D matrix built only by using a magnetic sensor-equipped catheter.
Furthermore, NavX technology is partially insensitive to potential patient movements, as the coordinate system (patches) are linked to the patient, and therefore they move simultaneously with the patient, preventing map shifts.
On the other hand, the impedance-based localization system used by EnSite is subject to changes in tissue properties. Changes in the respiration pattern and volume shifts during the course of the procedure (e.g., secondary to saline infusion when using an irrigated ablation) can cause impedance changes inside the body and potentially impact the localization accuracy of the EnSite system. The newer version of EnSite (EnSite Precision) now uniquely combines impedance and magnetics, which can enhance navigation and model creation.
Rhythmia
The main advantage of Rhythmia is the ability to create ultra–high-resolution activation and voltage maps using rapid and accurate automated data acquisition and annotation. The very small size of the electrodes on the Orion catheter minimizes far-field signals and background noise and allows accurate detection of very small amplitude signals. Also, this system offers the ability to change the mapping window in retrospect (see Fig. 6.10 ).
Similar to the EnSite system, Rhythmia can acquire electroanatomical data from magnetically enabled catheters (Orion and ablation catheters) as well as catheter without magnetic sensors. Data acquisition from catheters without magnetic sensors can be acquired only after construction of the electromagnetic field using magnetically enabled catheters. Notably, Rhythmia does not allow for integration with CT or MRI.
This mapping technology is preferentially designed for complex cardiac arrhythmias like AF, macroreentrant atrial tachycardia (MRAT), and scar-related VT, especially for substrate analysis (voltage maps), and analysis of conduction pattern (activation maps), but also for maps promoting effective catheter ablation (e.g., mapping gap in ablation lines). However, further studies are required to explore the potential clinical benefits gained from such ultra–high-density mapping.